Why the study?
Does an early invasive strategy improve 30-day outcomes compared to a delayed invasive strategy in patients with high-risk NSTE-ACS?
Does an early invasive strategy improve 30-day outcomes compared to a delayed invasive strategy in patients with high-risk NSTE-ACS?
Answers are grounded in this paper and cite their sources.
An editorial discussing a Dutch registry finding that despite guideline recommendations, higher-risk NSTE-ACS patients often receive delayed invasive strategies, though without apparent adverse effects on 30-day outcomes compared to early intervention.
Contains fulltext : 202707.pdf (Publisher’s version ) (Open Access)
No takes yet. Share an insight, caveat, or question.
Damman et al. (2018) conducted an editorial in High-risk non-ST-elevation acute coronary syndrome (NSTE-ACS). Early invasive strategy vs. Delayed invasive strategy was evaluated on Mortality, reinfarction, and bleeding events at 30-day follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: